Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
2.560
-0.200 (-7.25%)
At close: Apr 1, 2025, 4:00 PM
2.690
+0.130 (5.08%)
Pre-market: Apr 2, 2025, 6:18 AM EDT
Terns Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
59
Market Cap
223.48M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
TERN News
- 12 days ago - Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates - GlobeNewsWire
- 4 weeks ago - Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 5 weeks ago - Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer - GlobeNewsWire
- 5 weeks ago - Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors - GlobeNewsWire
- 7 weeks ago - Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 2 months ago - Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 2 months ago - Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire